Omega Therapeutics, Inc.
OMGA · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $162,573 | $273,399 | $541,500 | $765,372 |
| - Cash | $68,443 | $70,615 | $186,482 | $22,951 |
| + Debt | $128,428 | $22,580 | $19,869 | $11,732 |
| Enterprise Value | $222,558 | $225,364 | $374,887 | $754,153 |
| Revenue | $3,094 | $2,073 | $144 | $0 |
| % Growth | 49.3% | 1,339.6% | – | – |
| Gross Profit | -$62,775 | -$3,117 | -$1,243 | -$1,146 |
| % Margin | -2,028.9% | -150.4% | -863.2% | – |
| EBITDA | -$93,490 | -$97,576 | -$64,645 | -$27,499 |
| % Margin | -3,021.7% | -4,707% | -44,892.4% | – |
| Net Income | -$97,428 | -$102,636 | -$69,162 | -$30,199 |
| % Margin | -3,148.9% | -4,951.1% | -48,029.2% | – |
| EPS Diluted | -1.8 | -2.14 | -1.45 | -0.63 |
| % Growth | 15.9% | -47.6% | -130.2% | – |
| Operating Cash Flow | -$91,510 | -$98,515 | -$57,609 | -$26,133 |
| Capital Expenditures | -$2,869 | -$1,380 | -$1,467 | -$1,808 |
| Free Cash Flow | -$94,379 | -$99,895 | -$59,076 | -$27,941 |